66478-1-Ig

antibody from Proteintech Group

Targeting: SMAD7 MADH7, MADH8

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

66478-1-Ig

Provider

Proteintech Group

Product name

SMAD7 antibody

Antibody type

Monoclonal

Description

SMAD7 antibody (Cat. #66478-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human, mouse, rat, pig and has been validated for the following applications: IHC, WB, ELISA.

Reactivity

Human, Mouse, Rat, Porcine

Host

Mouse

Conjugate

Unconjugated

Isotype

IgG

Antibody clone number

2B9A4

Vial size

20ul, 150ul

References

Submitted references

LncRNA RAD51-AS1 Regulates Human Bone Marrow Mesenchymal Stem Cells via Interaction with YBX1 to Ameliorate Osteoporosis.

Li B, Wang J, Xu F, Wang Q, Liu Q, Wang G, Miao D, Sun Q
Stem cell reviews and reports 2023 Jan;19(1):170-187

---

Nitroxoline suppresses metastasis in bladder cancer via EGR1/circNDRG1/miR-520h/smad7/EMT signaling pathway.

Ren L, Jiang M, Xue D, Wang H, Lu Z, Ding L, Xie H, Wang R, Luo W, Xu L, Wang M, Yu S, Cheng S, Xia L, Yu H, Huang P, Xu N, Li G
International journal of biological sciences 2022;18(13):5207-5220

---

The multifunctional adaptor protein HIP-55 couples Smad7 to accelerate TGF-β type I receptor degradation.

Sun Y, Li ZJ
Acta pharmacologica Sinica 2022 Mar;43(3):634-644

---

Phosphatidylserine eversion regulated by phospholipid scramblase activated by TGF-β1/Smad signaling in the early stage of kidney stone formation.

Gan XG, Xu HT, Wang ZH
Urolithiasis 2022 Feb;50(1):11-20

---

Emodin ameliorates tubulointerstitial fibrosis in obstructed kidneys by inhibiting EZH2.

Xu L, Gao J, Huang D, Lin P, Yao D, Yang F, Zhang Y, Yang X, Wu M, Ye C
Biochemical and biophysical research communications 2021 Jan 1;534:279-285

---

Exosomes derived from thymic stromal lymphopoietin-treated dendritic cells regulate T helper 17/regulatory T cell differentiation via miR-21/Smad7 axis.

Ji Q, Liu J, Dong Y, Wang L, Dong K, Setiz B, Szentmáry N, Qu B, Shi L
Experimental cell research 2021 Jan 1;398(1):112393

---

LINC00968 can inhibit the progression of lung adenocarcinoma through the miR-21-5p/SMAD7 signal axis.

Zhu Y, Bo H, Chen Z, Li J, He D, Xiao M, Xiang L, Jin L, Zhou J, Gong L, Zhou Y, Zhou M, Xiong W, Xing X, Li R, Cao K
Aging 2020 Nov 4;12(21):21904-21922

---

Wu-Mei-Wan ameliorates chronic colitis-associated intestinal fibrosis through inhibiting fibroblast activation.

Wu F, Shao Q, Hu M, Zhao Y, Dong R, Fang K, Xu L, Zou X, Lu F, Li J, Chen G
Journal of ethnopharmacology 2020 Apr 24;252:112580

---

Yu Gan Long reduces rat liver fibrosis by blocking TGF-β1/Smad pathway and modulating the immunity.

Xia Y, Yu B, Ma C, Tu Y, Zhai L, Yang Y, Liu D, Liu Y, Wu H, Dan H, You P
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2018 Oct;106:1332-1338